Search
for
Sort by
Research 31–60 of 1000+
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Under Development JAK Inhibitors for Dermatologic Diseases
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Janus Kinase inhibitors in dermatology: a review
- The Role of Janus Kinase Inhibitors in Dermatology
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Theoretical investigation on the construction of hair follicle membranes and the transdermal drug delivery mechanisms of JAK inhibitors via distinct pathways
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- IN-SILICO STUDY OF BIOACTIVE COMPOUNDS OF NATURAL MATERIALS AS A JAK- SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION INHIBITOR FOR ANTI-ALOPECIA
- Mesenchymal Stem Cells Antagonize IFN-Induced Proinflammatory Changes and Growth Inhibition Effects via Wnt/β-Catenin and JAK/STAT Pathway in Human Outer Root Sheath Cells and Hair Follicles
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Immune cell regulation of the hair cycle
- New drugs under investigation for the treatment of alopecias